Related Experiment Video
Updated: Jul 25, 2025
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.9K
POCT errors can lead to false potassium results.
1Clinical Laboratory Department, Hospital Universitario La Paz, Madrid, Spain.
Advances in Laboratory Medicine
|June 26, 2023
Summary
Hemolysis in blood samples can cause inaccurate potassium readings during point-of-care testing, leading to misdiagnosis. Proper quality control in point-of-care testing programs is crucial to ensure reliable results and patient safety.
Area of Science:
- Clinical Chemistry
- Point-of-Care Diagnostics
- Laboratory Medicine
Background:
- Point-of-care testing (POCT) provides rapid results for critical decisions, but sample quality is paramount.
- Blood gas analyzers are widely used in emergency settings, often with whole blood samples.
- Hemolysis, a common issue in blood samples, can significantly impact test results.
Purpose of the Study:
- To review the causes of falsely elevated potassium concentrations due to hemolysis in POCT.
- To highlight the diagnostic and clinical implications of hemolysis-induced pseudohyperkalemia.
- To emphasize the role of laboratory-led POCT programs in error prevention.
Main Methods:
- Literature review focusing on hemolysis and potassium measurement in POCT.
- Analysis of how hemolysis affects blood gas analyzer parameters.
- Discussion of diagnostic pitfalls and clinical consequences.
Main Results:
- Hemolysis is a frequent cause of pseudohyperkalemia (falsely high potassium) or pseudonormokalemia (falsely normal potassium).
- These alterations can lead to incorrect diagnoses and inappropriate patient management.
- POCT devices typically do not detect sample hemolysis, and visual detection is often unreliable.
Conclusions:
- Accurate POCT results depend on sample integrity, particularly the absence of hemolysis.
- Clinical laboratories must implement robust POCT programs to mitigate hemolysis-related errors.
- Effective quality management is essential for safe and reliable point-of-care testing.
Related Concept Videos
01:25Errors occurring during blood pressure monitoring
781
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
781
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
654
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
654
01:24Diagnosing Acidosis and Alkalosis
273
Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
273
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.1K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.1K
01:13Accuracy and Errors in Hypothesis Testing
229
Hypothesis testing is a fundamental statistical tool that begins with the assumption that the null hypothesis H0 is true. During this process, two types of errors can occur: Type I and Type II. A Type I error refers to the incorrect rejection of a true null hypothesis, while a Type II error involves the failure to reject a false null hypothesis.
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
229
01:20Antiepileptic Drugs: Potassium Channel Activators
217
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
217